- Home
- KYMR vs UEC Comparison
KYMR vs UEC Comparison
Compare KYMR & UEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- UEC
- Stock Information
- Founded
- KYMR 2015
- UEC 2003
- Country
- KYMR United States
- UEC United States
- Employees
- KYMR N/A
- UEC N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- UEC Other Metals and Minerals
- Sector
- KYMR Health Care
- UEC Basic Materials
- Exchange
- KYMR Nasdaq
- UEC Nasdaq
- Market Cap
- KYMR 2.2B
- UEC 2.0B
- IPO Year
- KYMR 2020
- UEC N/A
- Fundamental
- Price
- KYMR $25.97
- UEC $5.05
- Analyst Decision
- KYMR Buy
- UEC Strong Buy
- Analyst Count
- KYMR 13
- UEC 2
- Target Price
- KYMR $56.69
- UEC $11.25
- AVG Volume (30 Days)
- KYMR 847.3K
- UEC 9.5M
- Earning Date
- KYMR 05-01-2025
- UEC 06-09-2025
- Dividend Yield
- KYMR N/A
- UEC N/A
- EPS Growth
- KYMR N/A
- UEC N/A
- EPS
- KYMR N/A
- UEC N/A
- Revenue
- KYMR $47,072,000.00
- UEC $66,837,000.00
- Revenue This Year
- KYMR $16.24
- UEC $60,962.50
- Revenue Next Year
- KYMR $22.41
- UEC $34.61
- P/E Ratio
- KYMR N/A
- UEC N/A
- Revenue Growth
- KYMR N/A
- UEC 12.54
- 52 Week Low
- KYMR $19.45
- UEC $3.85
- 52 Week High
- KYMR $53.27
- UEC $8.93
- Technical
- Relative Strength Index (RSI)
- KYMR 44.70
- UEC 53.06
- Support Level
- KYMR $24.43
- UEC $4.56
- Resistance Level
- KYMR $26.06
- UEC $5.13
- Average True Range (ATR)
- KYMR 2.36
- UEC 0.38
- MACD
- KYMR 0.41
- UEC 0.09
- Stochastic Oscillator
- KYMR 70.12
- UEC 93.75
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About UEC Uranium Energy Corp.
Uranium Energy Corp is engaged in uranium mining and related activities. The company is working towards fueling the demand for carbon-free nuclear energy, a key solution to climate change, and energy source for the low-carbon future. The company is advancing its next generation of low-cost, environmentally friendly, in-situ recovery (ISR) mining uranium projects. The company has two extraction-ready ISR hub and spoke platforms in South Texas and Wyoming. UEC also has seven U.S. ISR uranium projects with all of their permits in place, with additional diversified holdings of uranium assets across the U.S., Canada and Paraguay.